日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mnemonic of Principles for Effective Specialist-Generalist Conferences: The BRIDGE

有效专家-通才会议原则记忆法:BRIDGE

Kanzawa, Yohei; Tetsuou Tsukada, Yayoi; Ishibashi, Kenta; Ono, Masataka; Matsushima, Yui; Shingu, Motohiro; Saito, Hideki; Tamita, Koichi; Ishimaru, Naoto

Cardiac Rehabilitation for Patients With Stable Ischemic Heart Disease Without Revascularization - Rationale and Design of a Single-Arm Pilot Study

针对未接受血运重建的稳定型缺血性心脏病患者的心脏康复——单臂试点研究的原理和设计

Seki, Tomotsugu; Murata, Makoto; Takabayashi, Kensuke; Yanagisawa, Takashi; Ogihara, Masayuki; Kurimoto, Ritsuko; Kida, Keisuke; Tamita, Koichi; Song, Xiaoyang; Ozasa, Neiko; Taniguchi, Ryoji; Nishitani-Yokoyama, Miho; Koba, Shinji; Murai, Ryosuke; Furukawa, Yutaka; Hamasaki, Maki; Kondo, Hirokazu; Hayashi, Hironori; Ootakara-Katsume, Asako; Tateishi, Kento; Matoba, Satoaki; Adachi, Hitoshi; Shiraishi, Hirokazu

Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial

β受体阻滞剂与钙通道阻滞剂在药物洗脱支架植入术后诱发血管痉挛性心绞痛方面的比较:一项多中心前瞻性随机试验

Sawano, Mitsuaki; Katsuki, Toshiomi; Kitai, Takeshi; Tamita, Koichi; Obunai, Kotaro; Ikegami, Yukinori; Yamane, Takafumi; Ueda, Ikuko; Endo, Ayaka; Maekawa, Yuichiro; Kawamura, Akio; Fukuda, Keiichi; Kohsaka, Shun

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

更正:血浆溶血磷脂酰胆碱 (lyso-Gb3) 作为生物标志物在多专科诊所筛选法布里病高危患者进行基因分析方面的有效性

Maruyama, Hiroki; Miyata, Kaori; Mikame, Mariko; Taguchi, Atsumi; Guili, Chu; Shimura, Masaru; Murayama, Kei; Inoue, Takeshi; Yamamoto, Saori; Sugimura, Koichiro; Tamita, Koichi; Kawasaki, Toshihiro; Kajihara, Jun; Onishi, Akifumi; Sugiyama, Hitoshi; Sakai, Teiko; Murata, Ichijiro; Oda, Takamasa; Toyoda, Shigeru; Hanawa, Kenichiro; Fujimura, Takeo; Ura, Shigehisa; Matsumura, Mimiko; Takano, Hideki; Yamashita, Satoshi; Matsukura, Gaku; Tazawa, Ryushi; Shiga, Tsuyoshi; Ebato, Mio; Satoh, Hiroshi; Ishii, Satoshi

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis

血浆溶血磷脂酰胆碱 (lyso-Gb3) 作为生物标志物在多专科诊所筛选法布里病高危患者进行基因分析中的有效性

Maruyama, Hiroki; Miyata, Kaori; Mikame, Mariko; Taguchi, Atsumi; Guili, Chu; Shimura, Masaru; Murayama, Kei; Inoue, Takeshi; Yamamoto, Saori; Sugimura, Koichiro; Tamita, Koichi; Kawasaki, Toshihiro; Kajihara, Jun; Onishi, Akifumi; Sugiyama, Hitoshi; Sakai, Teiko; Murata, Ichijiro; Oda, Takamasa; Toyoda, Shigeru; Hanawa, Kenichiro; Fujimura, Takeo; Ura, Shigehisa; Matsumura, Mimiko; Takano, Hideki; Yamashita, Satoshi; Matsukura, Gaku; Tazawa, Ryushi; Shiga, Tsuyoshi; Ebato, Mio; Satoh, Hiroshi; Ishii, Satoshi

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study)

吡格列酮治疗既往有心肌梗死病史且患有轻度糖尿病的患者的心血管结局:日本评估吡格列酮是否能保护糖尿病患者免于再梗死工作组(PPAR 研究)的随机试验报告

Asakura, Masanori; Kim, Jiyoong; Asanuma, Hiroshi; Nakama, Yasuharu; Tsukahara, Kengo; Higashino, Yorihiko; Ishikawa, Tetsuya; Koba, Shinji; Tsujimoto, Mitsuru; Himeno, Hideo; Maruyama, Yasuyuki; Ookusa, Takanori; Yoda, Shunichi; Suzuki, Hiroshi; Okubo, Shinji; Shimizu, Makoto; Hashimoto, Yuji; Satake, Kazuo; Fujino, Susumu; Uzui, Hiroyasu; Nagai, Yoshiyuki; Kohno, Tohru; Mizuno, Sumio; Nakahama, Makoto; Kanaya, Hounin; Murohara, Toyoaki; Fukui, Kazuki; Takase, Hiroyuki; Ohte, Nobuyuki; Shiono, Takaaki; Fukunami, Masatake; Endo, Tsutomu; Sawada, Reimin; Fujii, Kenshi; Takeuchi, Motoshi; Ikeda, Shuntaro; Mizuno, Koichi; Uematsu, Masaaki; Matsubara, Taku; Yano, Shoji; Takahashi, Jun; Ueda, Kousei; Kinoshita, Yoshihiko; Tamita, Koichi; Hayashi, Hideki; Hamasaki, Toshimitsu; Kitakaze, Masafumi

Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor

TASP0433864(一种新型代谢型谷氨酸 2 受体正变构调节剂)的神经生理学和抗精神病特性

Tetsuaki Hiyoshi, Toshiyuki Marumo, Hirohiko Hikichi, Yasumitsu Tomishima, Hiroki Urabe, Tomoko Tamita, Izumi Iida, Akito Yasuhara, Jun-ichi Karasawa, Shigeyuki Chaki

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations

新诊断的葡萄糖耐量异常与急性心肌梗死后的预后:餐后血糖浓度与空腹血糖浓度的比较

Tamita, Koichi; Katayama, Minako; Takagi, Tsutomu; Yamamuro, Atsushi; Kaji, Shuichiro; Yoshikawa, Junichi; Furukawa, Yutaka

Quantitative assessment of harmonic power doppler myocardial perfusion imaging with intravenous Levovist in patients with myocardial infarction: comparison with myocardial viability evaluated by coronary flow reserve and coronary flow pattern of infarct-related artery

对心肌梗死患者静脉注射Levovist后进行谐波功率多普勒心肌灌注显像的定量评估:与通过冠状动脉血流储备和梗死相关动脉冠状动脉血流模式评估的心肌存活率进行比较

Tani, Tomoko; Tanabe, Kazuaki; Tani, Minako; Ono, Fumie; Katayama, Minako; Tamita, Koichi; Kaji, Shuichiro; Yamamuro, Atsushi; Nagai, Kunihiko; Shiratori, Kenichi; Morioka, Shigefumi; Kihara, Yasuki